Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

ENBREL MYCLIC

Class 5Status: Registered
Application Number1506217
Trademark Status
Registered
Trademark Class5
Application Date2006-11-21
Proprietor Name(1) WYETH LLCBody Incorporate
Appropriate OfficeMUMBAI
StateMAHARASHTRA
Trademark TypeWORD
User DetailsProposed to be used
Agent NameDE PENNING & DE PENNING[9197]
Agent AddressAlaknanda, 16 Nepean Sea Road, Mumbai 400036, India
Goods And Services Details[CLASS : 5] PHARMACEUTICAL PREPARATION IN A PRE-FILLED AUTOINJECTOR PEN TO TREAT RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, PSORIATIC ARTHRITIS, JUVENILE IDIOPATHIC ARTHRITIS AND PSORIASIS FALLING IN CLASS-5.Publication Details Published in Journal No. : 1393-0     Dated : 01/06/2008

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
ENBREL MYCLIC5Registered

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about ENBREL MYCLIC.

The current status of trademark application 1506217 for ENBREL MYCLIC is Registered.
ENBREL MYCLIC is registered under trademark class 5.
The proprietor of ENBREL MYCLIC is (1) WYETH LLCBody Incorporate.
Trademark application 1506217 for ENBREL MYCLIC was filed on 2006-11-21.